The global market for Coartem (Artemether & Lumefantrine) was valued at US$ 45940 million in the year 2024 and is projected to reach a revised size of US$ 60620 million by 2031, growing at a CAGR of 4.1% during the forecast period.

Coartem (Artemether & Lumefantrine) Market

North American market for Coartem (Artemether & Lumefantrine) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Coartem (Artemether & Lumefantrine) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Coartem (Artemether & Lumefantrine) include Novartis, Sanofi-Aventis, KPC Pharmaceuticals, Inc, Guangxi Xiancaotang Pharmaceutical Co., LTD, Guilin Pharmaceutical Co., Ltd, Kerui Nanhai Pharmaceutical, Kunming Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Coartem (Artemether & Lumefantrine), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coartem (Artemether & Lumefantrine).

The Coartem (Artemether & Lumefantrine) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Coartem (Artemether & Lumefantrine) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Coartem (Artemether & Lumefantrine) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Coartem (Artemether & Lumefantrine) Market Report

Report Metric	Details
Report Name	Coartem (Artemether & Lumefantrine) Market
Accounted market size in year	US$ 45940 million
Forecasted market size in 2031	US$ 60620 million
CAGR	4.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Artemether Lumefantrine
Segment by Application	Hospital Pharmacy Retail Pharmacy Online Pharmacy
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Novartis, Sanofi-Aventis, KPC Pharmaceuticals, Inc, Guangxi Xiancaotang Pharmaceutical Co., LTD, Guilin Pharmaceutical Co., Ltd, Kerui Nanhai Pharmaceutical, Kunming Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Coartem (Artemether & Lumefantrine) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Coartem (Artemether & Lumefantrine) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Coartem (Artemether & Lumefantrine) Market growing?

Ans: The Coartem (Artemether & Lumefantrine) Market witnessing a CAGR of 4.1% during the forecast period 2025-2031.

What is the Coartem (Artemether & Lumefantrine) Market size in 2031?

Ans: The Coartem (Artemether & Lumefantrine) Market size in 2031 will be US$ 60620 million.

Who are the main players in the Coartem (Artemether & Lumefantrine) Market report?

Ans: The main players in the Coartem (Artemether & Lumefantrine) Market are Novartis, Sanofi-Aventis, KPC Pharmaceuticals, Inc, Guangxi Xiancaotang Pharmaceutical Co., LTD, Guilin Pharmaceutical Co., Ltd, Kerui Nanhai Pharmaceutical, Kunming Pharmaceutical

What are the Application segmentation covered in the Coartem (Artemether & Lumefantrine) Market report?

Ans: The Applications covered in the Coartem (Artemether & Lumefantrine) Market report are Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

What are the Type segmentation covered in the Coartem (Artemether & Lumefantrine) Market report?

Ans: The Types covered in the Coartem (Artemether & Lumefantrine) Market report are Artemether, Lumefantrine

1 Coartem (Artemether & Lumefantrine) Market Overview

1.1 Product Definition

1.2 Coartem (Artemether & Lumefantrine) by Type

1.2.1 Global Coartem (Artemether & Lumefantrine) Market Value Comparison by Type (2024 VS 2031)

1.2.2 Artemether

1.2.3 Lumefantrine

1.3 Coartem (Artemether & Lumefantrine) by Application

1.3.1 Global Coartem (Artemether & Lumefantrine) Market Value by Application (2024 VS 2031)

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Online Pharmacy

1.4 Global Coartem (Artemether & Lumefantrine) Market Size Estimates and Forecasts

1.4.1 Global Coartem (Artemether & Lumefantrine) Revenue 2020-2031

1.4.2 Global Coartem (Artemether & Lumefantrine) Sales 2020-2031

1.4.3 Global Coartem (Artemether & Lumefantrine) Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Coartem (Artemether & Lumefantrine) Market Competition by Manufacturers

2.1 Global Coartem (Artemether & Lumefantrine) Sales Market Share by Manufacturers (2020-2025)

2.2 Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Coartem (Artemether & Lumefantrine) Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Coartem (Artemether & Lumefantrine), Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Coartem (Artemether & Lumefantrine), Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Coartem (Artemether & Lumefantrine), Product Type & Application

2.7 Global Key Manufacturers of Coartem (Artemether & Lumefantrine), Date of Enter into This Industry

2.8 Global Coartem (Artemether & Lumefantrine) Market Competitive Situation and Trends

2.8.1 Global Coartem (Artemether & Lumefantrine) Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Coartem (Artemether & Lumefantrine) Players Market Share by Revenue

2.8.3 Global Coartem (Artemether & Lumefantrine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Coartem (Artemether & Lumefantrine) Market Scenario by Region

3.1 Global Coartem (Artemether & Lumefantrine) Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Coartem (Artemether & Lumefantrine) Sales by Region: 2020-2031

3.2.1 Global Coartem (Artemether & Lumefantrine) Sales by Region: 2020-2025

3.2.2 Global Coartem (Artemether & Lumefantrine) Sales by Region: 2026-2031

3.3 Global Coartem (Artemether & Lumefantrine) Revenue by Region: 2020-2031

3.3.1 Global Coartem (Artemether & Lumefantrine) Revenue by Region: 2020-2025

3.3.2 Global Coartem (Artemether & Lumefantrine) Revenue by Region: 2026-2031

3.4 North America Coartem (Artemether & Lumefantrine) Market Facts & Figures by Country

3.4.1 North America Coartem (Artemether & Lumefantrine) Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Coartem (Artemether & Lumefantrine) Sales by Country (2020-2031)

3.4.3 North America Coartem (Artemether & Lumefantrine) Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Coartem (Artemether & Lumefantrine) Market Facts & Figures by Country

3.5.1 Europe Coartem (Artemether & Lumefantrine) Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Coartem (Artemether & Lumefantrine) Sales by Country (2020-2031)

3.5.3 Europe Coartem (Artemether & Lumefantrine) Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Coartem (Artemether & Lumefantrine) Market Facts & Figures by Region

3.6.1 Asia Pacific Coartem (Artemether & Lumefantrine) Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Coartem (Artemether & Lumefantrine) Sales by Region (2020-2031)

3.6.3 Asia Pacific Coartem (Artemether & Lumefantrine) Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Coartem (Artemether & Lumefantrine) Market Facts & Figures by Country

3.7.1 Latin America Coartem (Artemether & Lumefantrine) Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Coartem (Artemether & Lumefantrine) Sales by Country (2020-2031)

3.7.3 Latin America Coartem (Artemether & Lumefantrine) Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Coartem (Artemether & Lumefantrine) Market Facts & Figures by Country

3.8.1 Middle East and Africa Coartem (Artemether & Lumefantrine) Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Coartem (Artemether & Lumefantrine) Sales by Country (2020-2031)

3.8.3 Middle East and Africa Coartem (Artemether & Lumefantrine) Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Coartem (Artemether & Lumefantrine) Sales by Type (2020-2031)

4.1.1 Global Coartem (Artemether & Lumefantrine) Sales by Type (2020-2025)

4.1.2 Global Coartem (Artemether & Lumefantrine) Sales by Type (2026-2031)

4.1.3 Global Coartem (Artemether & Lumefantrine) Sales Market Share by Type (2020-2031)

4.2 Global Coartem (Artemether & Lumefantrine) Revenue by Type (2020-2031)

4.2.1 Global Coartem (Artemether & Lumefantrine) Revenue by Type (2020-2025)

4.2.2 Global Coartem (Artemether & Lumefantrine) Revenue by Type (2026-2031)

4.2.3 Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Type (2020-2031)

4.3 Global Coartem (Artemether & Lumefantrine) Price by Type (2020-2031)

5 Segment by Application

5.1 Global Coartem (Artemether & Lumefantrine) Sales by Application (2020-2031)

5.1.1 Global Coartem (Artemether & Lumefantrine) Sales by Application (2020-2025)

5.1.2 Global Coartem (Artemether & Lumefantrine) Sales by Application (2026-2031)

5.1.3 Global Coartem (Artemether & Lumefantrine) Sales Market Share by Application (2020-2031)

5.2 Global Coartem (Artemether & Lumefantrine) Revenue by Application (2020-2031)

5.2.1 Global Coartem (Artemether & Lumefantrine) Revenue by Application (2020-2025)

5.2.2 Global Coartem (Artemether & Lumefantrine) Revenue by Application (2026-2031)

5.2.3 Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Application (2020-2031)

5.3 Global Coartem (Artemether & Lumefantrine) Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Novartis

6.1.1 Novartis Company Information

6.1.2 Novartis Description and Business Overview

6.1.3 Novartis Coartem (Artemether & Lumefantrine) Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Novartis Coartem (Artemether & Lumefantrine) Product Portfolio

6.1.5 Novartis Recent Developments/Updates

6.2 Sanofi-Aventis

6.2.1 Sanofi-Aventis Company Information

6.2.2 Sanofi-Aventis Description and Business Overview

6.2.3 Sanofi-Aventis Coartem (Artemether & Lumefantrine) Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Sanofi-Aventis Coartem (Artemether & Lumefantrine) Product Portfolio

6.2.5 Sanofi-Aventis Recent Developments/Updates

6.3 KPC Pharmaceuticals, Inc

6.3.1 KPC Pharmaceuticals, Inc Company Information

6.3.2 KPC Pharmaceuticals, Inc Description and Business Overview

6.3.3 KPC Pharmaceuticals, Inc Coartem (Artemether & Lumefantrine) Sales, Revenue and Gross Margin (2020-2025)

6.3.4 KPC Pharmaceuticals, Inc Coartem (Artemether & Lumefantrine) Product Portfolio

6.3.5 KPC Pharmaceuticals, Inc Recent Developments/Updates

6.4 Guangxi Xiancaotang Pharmaceutical Co., LTD

6.4.1 Guangxi Xiancaotang Pharmaceutical Co., LTD Company Information

6.4.2 Guangxi Xiancaotang Pharmaceutical Co., LTD Description and Business Overview

6.4.3 Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether & Lumefantrine) Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether & Lumefantrine) Product Portfolio

6.4.5 Guangxi Xiancaotang Pharmaceutical Co., LTD Recent Developments/Updates

6.5 Guilin Pharmaceutical Co., Ltd

6.5.1 Guilin Pharmaceutical Co., Ltd Company Information

6.5.2 Guilin Pharmaceutical Co., Ltd Description and Business Overview

6.5.3 Guilin Pharmaceutical Co., Ltd Coartem (Artemether & Lumefantrine) Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Guilin Pharmaceutical Co., Ltd Coartem (Artemether & Lumefantrine) Product Portfolio

6.5.5 Guilin Pharmaceutical Co., Ltd Recent Developments/Updates

6.6 Kerui Nanhai Pharmaceutical

6.6.1 Kerui Nanhai Pharmaceutical Company Information

6.6.2 Kerui Nanhai Pharmaceutical Description and Business Overview

6.6.3 Kerui Nanhai Pharmaceutical Coartem (Artemether & Lumefantrine) Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Kerui Nanhai Pharmaceutical Coartem (Artemether & Lumefantrine) Product Portfolio

6.6.5 Kerui Nanhai Pharmaceutical Recent Developments/Updates

6.7 Kunming Pharmaceutical

6.7.1 Kunming Pharmaceutical Company Information

6.7.2 Kunming Pharmaceutical Description and Business Overview

6.7.3 Kunming Pharmaceutical Coartem (Artemether & Lumefantrine) Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Kunming Pharmaceutical Coartem (Artemether & Lumefantrine) Product Portfolio

6.7.5 Kunming Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Coartem (Artemether & Lumefantrine) Industry Chain Analysis

7.2 Coartem (Artemether & Lumefantrine) Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Coartem (Artemether & Lumefantrine) Production Mode & Process Analysis

7.4 Coartem (Artemether & Lumefantrine) Sales and Marketing

7.4.1 Coartem (Artemether & Lumefantrine) Sales Channels

7.4.2 Coartem (Artemether & Lumefantrine) Distributors

7.5 Coartem (Artemether & Lumefantrine) Customer Analysis

8 Coartem (Artemether & Lumefantrine) Market Dynamics

8.1 Coartem (Artemether & Lumefantrine) Industry Trends

8.2 Coartem (Artemether & Lumefantrine) Market Drivers

8.3 Coartem (Artemether & Lumefantrine) Market Challenges

8.4 Coartem (Artemether & Lumefantrine) Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Novartis

Sanofi Aventis

KPC Pharmaceuticals, Inc

Guangxi Xiancaotang Pharmaceutical Co., LTD

Guilin Pharmaceutical Co., Ltd

Kerui Nanhai Pharmaceutical

Kunming Pharmaceutical

List of Tables

Table 1. Global Coartem (Artemether & Lumefantrine) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Coartem (Artemether & Lumefantrine) Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Coartem (Artemether & Lumefantrine) Market Competitive Situation by Manufacturers in 2024

Table 4. Global Coartem (Artemether & Lumefantrine) Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Coartem (Artemether & Lumefantrine) Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Coartem (Artemether & Lumefantrine) Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Coartem (Artemether & Lumefantrine) Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Coartem (Artemether & Lumefantrine), Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Coartem (Artemether & Lumefantrine), Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Coartem (Artemether & Lumefantrine), Product Type & Application

Table 12. Global Key Manufacturers of Coartem (Artemether & Lumefantrine), Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Coartem (Artemether & Lumefantrine) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coartem (Artemether & Lumefantrine) as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Coartem (Artemether & Lumefantrine) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Coartem (Artemether & Lumefantrine) Sales by Region (2020-2025) & (K Units)

Table 18. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Region (2020-2025)

Table 19. Global Coartem (Artemether & Lumefantrine) Sales by Region (2026-2031) & (K Units)

Table 20. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Region (2026-2031)

Table 21. Global Coartem (Artemether & Lumefantrine) Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Region (2020-2025)

Table 23. Global Coartem (Artemether & Lumefantrine) Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Region (2026-2031)

Table 25. North America Coartem (Artemether & Lumefantrine) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Coartem (Artemether & Lumefantrine) Sales by Country (2020-2025) & (K Units)

Table 27. North America Coartem (Artemether & Lumefantrine) Sales by Country (2026-2031) & (K Units)

Table 28. North America Coartem (Artemether & Lumefantrine) Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Coartem (Artemether & Lumefantrine) Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Coartem (Artemether & Lumefantrine) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Coartem (Artemether & Lumefantrine) Sales by Country (2020-2025) & (K Units)

Table 32. Europe Coartem (Artemether & Lumefantrine) Sales by Country (2026-2031) & (K Units)

Table 33. Europe Coartem (Artemether & Lumefantrine) Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Coartem (Artemether & Lumefantrine) Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Coartem (Artemether & Lumefantrine) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Coartem (Artemether & Lumefantrine) Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Coartem (Artemether & Lumefantrine) Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Coartem (Artemether & Lumefantrine) Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Coartem (Artemether & Lumefantrine) Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Coartem (Artemether & Lumefantrine) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Coartem (Artemether & Lumefantrine) Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Coartem (Artemether & Lumefantrine) Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Coartem (Artemether & Lumefantrine) Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Coartem (Artemether & Lumefantrine) Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Coartem (Artemether & Lumefantrine) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Coartem (Artemether & Lumefantrine) Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Coartem (Artemether & Lumefantrine) Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Coartem (Artemether & Lumefantrine) Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Coartem (Artemether & Lumefantrine) Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Coartem (Artemether & Lumefantrine) Sales (K Units) by Type (2020-2025)

Table 51. Global Coartem (Artemether & Lumefantrine) Sales (K Units) by Type (2026-2031)

Table 52. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Type (2020-2025)

Table 53. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Type (2026-2031)

Table 54. Global Coartem (Artemether & Lumefantrine) Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Coartem (Artemether & Lumefantrine) Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Type (2020-2025)

Table 57. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Type (2026-2031)

Table 58. Global Coartem (Artemether & Lumefantrine) Price (USD/Unit) by Type (2020-2025)

Table 59. Global Coartem (Artemether & Lumefantrine) Price (USD/Unit) by Type (2026-2031)

Table 60. Global Coartem (Artemether & Lumefantrine) Sales (K Units) by Application (2020-2025)

Table 61. Global Coartem (Artemether & Lumefantrine) Sales (K Units) by Application (2026-2031)

Table 62. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Application (2020-2025)

Table 63. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Application (2026-2031)

Table 64. Global Coartem (Artemether & Lumefantrine) Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Coartem (Artemether & Lumefantrine) Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Application (2020-2025)

Table 67. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Application (2026-2031)

Table 68. Global Coartem (Artemether & Lumefantrine) Price (USD/Unit) by Application (2020-2025)

Table 69. Global Coartem (Artemether & Lumefantrine) Price (USD/Unit) by Application (2026-2031)

Table 70. Novartis Company Information

Table 71. Novartis Description and Business Overview

Table 72. Novartis Coartem (Artemether & Lumefantrine) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Novartis Coartem (Artemether & Lumefantrine) Product

Table 74. Novartis Recent Developments/Updates

Table 75. Sanofi-Aventis Company Information

Table 76. Sanofi-Aventis Description and Business Overview

Table 77. Sanofi-Aventis Coartem (Artemether & Lumefantrine) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Sanofi-Aventis Coartem (Artemether & Lumefantrine) Product

Table 79. Sanofi-Aventis Recent Developments/Updates

Table 80. KPC Pharmaceuticals, Inc Company Information

Table 81. KPC Pharmaceuticals, Inc Description and Business Overview

Table 82. KPC Pharmaceuticals, Inc Coartem (Artemether & Lumefantrine) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. KPC Pharmaceuticals, Inc Coartem (Artemether & Lumefantrine) Product

Table 84. KPC Pharmaceuticals, Inc Recent Developments/Updates

Table 85. Guangxi Xiancaotang Pharmaceutical Co., LTD Company Information

Table 86. Guangxi Xiancaotang Pharmaceutical Co., LTD Description and Business Overview

Table 87. Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether & Lumefantrine) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether & Lumefantrine) Product

Table 89. Guangxi Xiancaotang Pharmaceutical Co., LTD Recent Developments/Updates

Table 90. Guilin Pharmaceutical Co., Ltd Company Information

Table 91. Guilin Pharmaceutical Co., Ltd Description and Business Overview

Table 92. Guilin Pharmaceutical Co., Ltd Coartem (Artemether & Lumefantrine) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Guilin Pharmaceutical Co., Ltd Coartem (Artemether & Lumefantrine) Product

Table 94. Guilin Pharmaceutical Co., Ltd Recent Developments/Updates

Table 95. Kerui Nanhai Pharmaceutical Company Information

Table 96. Kerui Nanhai Pharmaceutical Description and Business Overview

Table 97. Kerui Nanhai Pharmaceutical Coartem (Artemether & Lumefantrine) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Kerui Nanhai Pharmaceutical Coartem (Artemether & Lumefantrine) Product

Table 99. Kerui Nanhai Pharmaceutical Recent Developments/Updates

Table 100. Kunming Pharmaceutical Company Information

Table 101. Kunming Pharmaceutical Description and Business Overview

Table 102. Kunming Pharmaceutical Coartem (Artemether & Lumefantrine) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Kunming Pharmaceutical Coartem (Artemether & Lumefantrine) Product

Table 104. Kunming Pharmaceutical Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Coartem (Artemether & Lumefantrine) Distributors List

Table 108. Coartem (Artemether & Lumefantrine) Customers List

Table 109. Coartem (Artemether & Lumefantrine) Market Trends

Table 110. Coartem (Artemether & Lumefantrine) Market Drivers

Table 111. Coartem (Artemether & Lumefantrine) Market Challenges

Table 112. Coartem (Artemether & Lumefantrine) Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Product Picture of Coartem (Artemether & Lumefantrine)

Figure 2. Global Coartem (Artemether & Lumefantrine) Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Coartem (Artemether & Lumefantrine) Market Share by Type: 2024 & 2031

Figure 4. Artemether Product Picture

Figure 5. Lumefantrine Product Picture

Figure 6. Global Coartem (Artemether & Lumefantrine) Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Coartem (Artemether & Lumefantrine) Market Share by Application: 2024 & 2031

Figure 8. Hospital Pharmacy

Figure 9. Retail Pharmacy

Figure 10. Online Pharmacy

Figure 11. Global Coartem (Artemether & Lumefantrine) Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Coartem (Artemether & Lumefantrine) Market Size (2020-2031) & (US$ Million)

Figure 13. Global Coartem (Artemether & Lumefantrine) Sales (2020-2031) & (K Units)

Figure 14. Global Coartem (Artemether & Lumefantrine) Average Price (USD/Unit) & (2020-2031)

Figure 15. Coartem (Artemether & Lumefantrine) Report Years Considered

Figure 16. Coartem (Artemether & Lumefantrine) Sales Share by Manufacturers in 2024

Figure 17. Global Coartem (Artemether & Lumefantrine) Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Coartem (Artemether & Lumefantrine) Players: Market Share by Revenue in Coartem (Artemether & Lumefantrine) in 2024

Figure 19. Coartem (Artemether & Lumefantrine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Coartem (Artemether & Lumefantrine) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Coartem (Artemether & Lumefantrine) Sales Market Share by Country (2020-2031)

Figure 22. North America Coartem (Artemether & Lumefantrine) Revenue Market Share by Country (2020-2031)

Figure 23. U.S. Coartem (Artemether & Lumefantrine) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Coartem (Artemether & Lumefantrine) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Coartem (Artemether & Lumefantrine) Sales Market Share by Country (2020-2031)

Figure 26. Europe Coartem (Artemether & Lumefantrine) Revenue Market Share by Country (2020-2031)

Figure 27. Germany Coartem (Artemether & Lumefantrine) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Coartem (Artemether & Lumefantrine) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Coartem (Artemether & Lumefantrine) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Coartem (Artemether & Lumefantrine) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Coartem (Artemether & Lumefantrine) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Coartem (Artemether & Lumefantrine) Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Coartem (Artemether & Lumefantrine) Revenue Market Share by Region (2020-2031)

Figure 34. China Coartem (Artemether & Lumefantrine) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Coartem (Artemether & Lumefantrine) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Coartem (Artemether & Lumefantrine) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Coartem (Artemether & Lumefantrine) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Coartem (Artemether & Lumefantrine) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Taiwan Coartem (Artemether & Lumefantrine) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Coartem (Artemether & Lumefantrine) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Coartem (Artemether & Lumefantrine) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Coartem (Artemether & Lumefantrine) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Philippines Coartem (Artemether & Lumefantrine) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Coartem (Artemether & Lumefantrine) Sales Market Share by Country (2020-2031)

Figure 45. Latin America Coartem (Artemether & Lumefantrine) Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Coartem (Artemether & Lumefantrine) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Coartem (Artemether & Lumefantrine) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Coartem (Artemether & Lumefantrine) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Coartem (Artemether & Lumefantrine) Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Coartem (Artemether & Lumefantrine) Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Coartem (Artemether & Lumefantrine) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Coartem (Artemether & Lumefantrine) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. U.A.E Coartem (Artemether & Lumefantrine) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Coartem (Artemether & Lumefantrine) by Type (2020-2031)

Figure 55. Global Revenue Market Share of Coartem (Artemether & Lumefantrine) by Type (2020-2031)

Figure 56. Global Coartem (Artemether & Lumefantrine) Price (USD/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Coartem (Artemether & Lumefantrine) by Application (2020-2031)

Figure 58. Global Revenue Market Share of Coartem (Artemether & Lumefantrine) by Application (2020-2031)

Figure 59. Global Coartem (Artemether & Lumefantrine) Price (USD/Unit) by Application (2020-2031)

Figure 60. Coartem (Artemether & Lumefantrine) Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions